CVS CVS Health Corporation Common Stock
$93,32
Prix · Aoû 24, 2026
Données fondamentales au Aoû 5, 2026
Fourchette 52 semaines
$70–$111
58% of range
Note des analystes
BUY
33 analysts
Objectif de cours
$116
+24% upside
P/E (TTM)
67.1
ROE
2.4%
Marge nette
0.44%
À propos de CVS Health Corporation Common Stock Présentation de l'entreprise depuis Wikipedia
CVS Caremark Corporation est une importante chaîne américaine de pharmacies, produits cosmétiques et soins, la plus importante du pays, devant Walgreens.
Lire la suite
CVS Caremark Corporation (NYSE : CVS) est une importante chaîne américaine de pharmacies, produits cosmétiques et soins, la plus importante du pays, devant Walgreens.
Initialement, ses initiales signifiaient Consumer Value Store.
Histoire
CVS Caremark est issu de la fusion en 2007 de Caremark et CVS/pharmacy. En 2010, elle se classait 18e entreprise américaine quant au chiffre d'affaires dans la liste établie par Fortune.
En novembre 2013, CVS acquiert Coram LLC, spécialisé dans les injections médicamenteuses, à Blackstone, pour 2,1 milliards de dollars.
En mai 2015, CVS annonce l'acquisition d'Omnicare, une entreprise américaine de services pharmaceutiques présente notamment dans les maisons de retraite, pour 10,1 milliards de dollars. En juin 2015, CVS annonce l'acquisition des 1 660 pharmacies de l'entreprise de grande distribution Target pour 1,9 milliard de dollars. En octobre 2017, CVS annonce l'acquisition de l'assureur médical Aetna pour plus de 66 milliards de dollars.
Le 15 janvier 2018, le groupe CVS Pharmacy annonce sur son site qu'il décide de ne plus retoucher ses photos publicitaires dont le lien entre la propagation d'images de corps irréalistes et les effets néfastes sur la santé des filles et des jeunes femmes a été établi ; cette décision sera effective sur tous les supports d'ici fin 2020.
Activités
Le groupe se divise en trois branches :
CVS pharmacy, qui gère les points de vente de médicaments
CVS Caremark Pharmacy Services, filiale de gestion des prestations pharmaceutiques, comme le renouvellement de prescriptions
MinuteClinic, qui fournit des services de cliniques de détail
CSV Health totalise plus de 7 000 points de vente dans 41 États américains [Quand ?].
== Références ==
Source : Wikipedia, CC BY-SA 4.0 · Voir sur Wikipedia ↗
CVS Aperçu de l'action Prix, capitalisation boursière, P/E, EPS, ROE, dette/capitaux propres, fourchette sur 52 semaines
Prix
$93.31
Capitalisation Boursière
$118.60B
P/E (TTM)
67.1
BPA (TTM)
$1.39
Revenus (TTM)
$402.07B
Rendement div.
2.9%
ROE
2.4%
Dette/Capitaux propres
0.0
Fourchette 52 semaines
$70 – $111
CVS Graphique du cours de l'action OHLCV quotidien avec indicateurs techniques — panoramique, zoom et personnalisez votre vue
Configure
Performance sur 10 ans Tendances du chiffre d'affaires, du bénéfice net, des marges et du BPA
Revenus et bénéfice net
$402.07B
2017-12-31
→
2025-12-31
BPA
$1.39
2017-12-31
→
2025-12-31
Flux de trésorerie libre
$7.81B
2017-12-31
→
2025-12-31
Marges
0.44%
2017-12-31
→
2017-12-31
Valorisation Ratios P/E, P/S, P/B, EV/EBITDA — l'action est-elle chère ou bon marché ?
Métrique
Tendance sur 5 ans
CVS
Médiane des pairs
P/E (TTM)
67.1
42.6
P/S (TTM)
0.3
0.3
P/B
1.6
0.9
EV / EBITDA
11.7
—
Price / FCF (Cours / FCF)
15.2
—
Rentabilité Marges brutes, d'exploitation et nettes ; ROE, ROA, ROIC
Métrique
Tendance sur 5 ans
CVS
Médiane des pairs
Operating Margin (Marge d'exploitation)
1.2%
—
Net Profit Margin (Marge nette)
0.44%
-7.0%
ROA
0.70%
-10.6%
ROE
2.4%
-20.8%
ROIC
5.0%
—
Santé financière Dette, liquidité, solvabilité — solidité du bilan
Métrique
Tendance sur 5 ans
CVS
Médiane des pairs
Debt / Equity (Dette / Capitaux propres)
0.0
8.0
Current Ratio (Ratio de liquidité)
0.8
1.1
Quick Ratio (Ratio de liquidité réduite)
0.6
—
Croissance Croissance du chiffre d'affaires, du BPA et du bénéfice net : Année/Année, TCAC 3 ans, TCAC 5 ans
Métrique
Tendance sur 5 ans
CVS
Médiane des pairs
Revenue YoY (Chiffre d'affaires YoY)
7.8%
—
Revenue CAGR 3Y (CAGR du chiffre d'affaires 3 ans)
7.6%
—
Revenue CAGR 5Y (CAGR du chiffre d'affaires 5 ans)
8.4%
—
EPS YoY (BPA Année/Année)
-62.0%
—
Net Income YoY (Bénéfice net YoY)
-61.7%
—
Efficacité du capital Rotation des actifs, rotation des stocks, rotation des créances
Métrique
Tendance sur 5 ans
CVS
Médiane des pairs
Payout Ratio (Ratio de distribution)
192.1%
—
Dividendes Rendement, ratio de distribution, historique des dividendes, CAGR à 5 ans
Rendement du Dividende
2.9%
Ratio de distribution
192.1%
CAGR des dividendes sur 5 ans
—
| Date ex-dividende | Montant |
|---|---|
| 23 juillet 2026 | $0,6650 |
| 23 avril 2026 | $0,6650 |
| 22 janvier 2026 | $0,6650 |
| 23 octobre 2025 | $0,6650 |
| 22 juillet 2025 | $0,6650 |
| 22 avril 2025 | $0,6650 |
| 23 janvier 2025 | $0,6650 |
| 21 octobre 2024 | $0,6650 |
| 22 juillet 2024 | $0,6650 |
| 19 avril 2024 | $0,6650 |
| 19 janvier 2024 | $0,6650 |
| 19 octobre 2023 | $0,6050 |
| 20 juillet 2023 | $0,6050 |
| 20 avril 2023 | $0,6050 |
| 19 janvier 2023 | $0,6050 |
| 20 octobre 2022 | $0,5500 |
| 21 juillet 2022 | $0,5500 |
| 21 avril 2022 | $0,5500 |
| 20 janvier 2022 | $0,5500 |
| 21 octobre 2021 | $0,5000 |
CVS Consensus des analystes Opinions des analystes haussières et baissières, objectif de cours à 12 mois, potentiel de hausse
ACHAT
33 analystes
- Achat fort 8 24,2%
- Achat 20 60,6%
- Conserver 5 15,2%
- Vente 0 0,0%
- Vente forte 0 0,0%
Objectif de cours à 12 mois
25 analystes · 2026-08-24
Médiane
$116.00
← En dessous de tous les objectifs
$93.31
Bas
$103.00
Haut
$148.00
Objectif médian
$116.00
+24,3%
Objectif moyen
$116.08
+24,4%
Historique des bénéfices BPA réel vs estimation, surprise %, taux de succès, prochaine date de publication des résultats
Surprise Moyenne
0.37%
| Période | EPS Actual | BPA est. | Surprise |
|---|---|---|---|
| 30 juin 2026 | $2.58 | $1.87 | 0.71% |
| 31 mars 2026 | $2.57 | $2.22 | 0.35% |
| 31 décembre 2025 | $1.09 | $1.00 | 0.09% |
| 30 septembre 2025 | $1.60 | $1.38 | 0.22% |
| 30 juin 2025 | $1.81 | $1.47 | 0.34% |
| 31 mars 2025 | $2.25 | $1.72 | 0.53% |
Comparaison des pairs (sous-secteur GICS) Indicateurs clés par rapport aux pairs du secteur
| Ticker | Capitalisation Boursière | P/E | Revenus Année/Année | Marge Nette | ROE | Marge Brute |
|---|---|---|---|---|---|---|
| CVS | $100.87B | 57.1 | 7.8% | 0.44% | 2.4% | — |
| CI | $72.51B | 12.4 | 11.2% | 2.2% | 14.4% | — |
| LH | $20.62B | 24.0 | 7.2% | 6.3% | 10.3% | 28.8% |
| DGX | $19.09B | 19.8 | 11.8% | 9.0% | 14.2% | — |
| GH | $13.34B | -30.8 | 32.9% | -42.4% | 205.7% | — |
| LH | $20.62B | 24.0 | 7.2% | 6.3% | 10.3% | 28.8% |
| BTSG | $7.20B | 43.0 | 28.2% | 1.5% | 10.8% | 11.8% |
| DVA | $7.79B | 11.5 | 6.5% | 5.5% | -281.8% | — |
| HIMS | — | 63.7 | 59.0% | 5.5% | 23.3% | 73.8% |
| HNGE | $0 | -6.0 | 50.6% | -89.9% | -299.8% | 79.7% |
| CHE | — | 23.3 | 4.1% | 10.5% | 24.4% | — |
Fondamentaux complets Tous les indicateurs par an — compte de résultat, bilan, flux de trésorerie
Compte de résultat 16
| Métrique | Tendance | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $402.07B | $372.81B | $357.78B | $322.47B | $292.11B | $268.71B | $256.78B | · | $184.79B | $177.55B | $153.29B | |
| Cost of Revenue | $221.17B | $206.29B | $217.10B | $196.89B | $175.80B | $163.98B | $158.72B | · | $153.45B | $146.53B | $126.76B | |
| Gross Profit | · | · | · | · | · | · | · | · | $28.55B | $28.86B | $26.53B | |
| Operating Expenses | $397.41B | $364.29B | $344.03B | $314.51B | $278.80B | $254.79B | $244.79B | · | $18.81B | $18.45B | $17.05B | |
| Operating Income | $4.66B | $8.52B | $13.74B | $7.95B | $13.31B | $13.91B | $11.99B | · | $9.54B | $10.39B | $9.47B | |
| Interest Expense | · | · | $2.66B | $2.29B | $2.50B | $2.91B | $3.04B | · | $1.06B | $1.08B | $859M | |
| Interest Income | · | · | · | · | · | · | · | · | $21M | $20M | $21M | |
| Other Non-op | $112M | $99M | $88M | $169M | $182M | $206M | $124M | · | $-208M | $-28M | · | |
| Pretax Income | $2.14B | $6.15B | $11.17B | $5.84B | $10.54B | $9.77B | $9.00B | · | $8.27B | $8.64B | $8.62B | |
| Income Tax | $408M | $1.56B | $2.81B | $1.51B | $2.55B | $2.57B | $2.37B | · | $1.64B | $3.32B | $3.39B | |
| Net Income | $1.77B | $4.61B | $8.34B | $4.31B | $8.00B | $7.18B | $6.63B | · | $6.62B | $5.32B | $5.24B | |
| EPS (Basic) | $1.40 | $3.67 | $6.49 | $3.29 | $6.07 | $5.48 | $5.10 | · | $6.47 | $4.93 | $4.66 | |
| EPS (Diluted) | $1.39 | $3.66 | $6.47 | $3.26 | $6.02 | $5.46 | $5.08 | · | $6.44 | $4.90 | $4.63 | |
| Shares (Basic) | 1,267,000,000 | 1,259,000,000 | 1,285,000,000 | 1,312,000,000 | 1,319,000,000 | 1,309,000,000 | 1,301,000,000 | · | 1,020,000,000 | 1,073,000,000 | 1,118,000,000 | |
| Shares (Diluted) | 1,271,000,000 | 1,262,000,000 | 1,290,000,000 | 1,323,000,000 | 1,329,000,000 | 1,314,000,000 | 1,305,000,000 | · | 1,024,000,000 | 1,079,000,000 | 1,126,000,000 | |
| EBITDA | $9.27B | $13.11B | $18.11B | $11.99B | $17.70B | $18.35B | $16.36B | · | $12.00B | $10.34B | $9.45B |
Bilan 31
| Métrique | Tendance | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $8.45B | $8.59B | $8.20B | $12.95B | $9.41B | $7.85B | $5.68B | · | $1.70B | $3.37B | $2.46B | |
| Short-term Investments | $2.15B | $2.41B | $3.26B | $2.78B | $3.12B | $3.00B | $2.37B | · | $111M | $87M | $88M | |
| Receivables | $39.78B | $36.47B | $35.23B | $27.28B | $24.43B | $21.74B | $19.62B | · | $13.18B | $12.16B | $11.89B | |
| Inventory | $19.25B | $18.11B | $18.02B | $19.09B | $17.76B | $18.50B | $17.52B | · | $15.30B | $14.76B | $14.00B | |
| Other Current Assets | $5.09B | $3.08B | $3.15B | $2.64B | $5.29B | $5.28B | $5.11B | $4.53B | $945M | $660M | $722M | |
| Current Assets | $74.71B | $68.64B | $67.86B | $65.63B | $60.01B | $56.37B | $50.30B | $45.20B | $31.23B | $31.04B | $29.16B | |
| PP&E (Net) | · | · | · | $12.87B | $12.90B | $12.61B | $12.04B | $11.36B | $10.29B | $10.18B | $9.86B | |
| PP&E (Gross) | · | · | · | $34.60B | $33.55B | $31.31B | $28.93B | · | $24.29B | $22.80B | $21.04B | |
| Accum. Depreciation | · | · | · | $21.48B | $20.65B | $18.70B | $16.89B | · | $14.00B | $12.63B | $11.18B | |
| Goodwill | $85.48B | $91.27B | $91.27B | $78.15B | $79.12B | $79.55B | $79.75B | · | $38.45B | $38.25B | $38.11B | |
| Intangibles | $25.51B | $27.32B | $29.23B | $24.80B | $29.03B | $31.14B | $33.12B | $36.31B | $13.63B | $13.51B | $13.88B | |
| Other Non-current Assets | $7.11B | $4.79B | $4.66B | $4.62B | $4.71B | $4.62B | $4.60B | $4.53B | $1.42B | $1.49B | $1.44B | |
| Total Assets | $253.54B | $253.22B | $249.73B | $228.28B | $233.00B | $230.72B | $222.45B | $216.67B | $95.13B | $94.46B | $92.44B | |
| Accounts Payable | · | · | · | · | · | · | · | · | $8.86B | $7.95B | $7.49B | |
| Accrued Liabilities | $22.39B | $20.81B | $23.52B | $18.75B | $17.67B | $14.24B | $12.13B | $10.66B | $6.58B | $6.94B | $6.83B | |
| Short-term Debt | $0 | $2.12B | $200M | $0 | · | $0 | $0 | · | $1.28B | $1.87B | $0 | |
| Current Liabilities | $88.69B | $84.61B | $79.19B | $69.42B | $67.81B | $62.02B | $53.30B | $45.76B | $30.65B | $26.25B | $23.17B | |
| Capital Leases | $13.64B | $14.90B | $16.03B | $16.80B | $18.18B | $18.76B | $18.93B | $18.83B | $306M | · | · | |
| Deferred Tax | $3.83B | $3.81B | $4.31B | $4.02B | $6.27B | $6.79B | $7.29B | $7.74B | $3.00B | $4.21B | $4.22B | |
| Other Non-current Liabilities | $6.77B | $5.43B | $6.21B | $6.73B | $1.90B | $2.35B | $2.16B | $2.26B | $1.28B | $1.55B | $1.54B | |
| Total Liabilities | $178.16B | $177.49B | $173.09B | $156.51B | $157.62B | $161.01B | $158.28B | $157.95B | $57.44B | · | · | |
| Long-term Debt | · | · | · | · | · | · | $68.48B | $72.61B | $27.00B | $25.70B | $27.50B | |
| Total Debt | $0 | $2.12B | $200M | · | · | · | $3.78B | · | $27.00B | $27.53B | $27.46B | |
| Common Stock | · | $18M | $18M | $18M | $17M | $17M | $17M | · | $17M | $17M | $17M | |
| Paid-in Capital | · | · | · | · | · | · | · | · | $32.08B | $31.62B | $30.95B | |
| Retained Earnings | $61.20B | $62.84B | $61.60B | $56.40B | $54.91B | $49.64B | $45.11B | $41.09B | $43.56B | $38.98B | $35.51B | |
| Treasury Stock | $36.79B | $36.82B | $33.84B | $31.86B | $28.17B | $28.18B | $28.23B | · | $37.80B | $33.45B | $28.89B | |
| AOCI | $406M | $-120M | $-297M | $-1.26B | $965M | $1.41B | $1.02B | · | $-165M | $-305M | $-358M | |
| Stockholders' Equity | $75.21B | $75.56B | $76.46B | $71.47B | $75.08B | $69.39B | $63.86B | $58.40B | $37.69B | $36.83B | $37.20B | |
| Liabilities + Equity | $253.54B | $253.22B | $249.73B | $228.28B | $233.00B | $230.72B | $222.45B | · | $95.13B | $94.46B | $92.44B | |
| Shares Outstanding | 1,271,000,000 | 1,260,000,000 | 1,288,000,000 | 1,300,000,000 | 1,322,000,000 | 1,310,000,000 | 1,302,000,000 | · | 1,712,000,000 | 1,061,000,000 | 1,101,000,000 |
Flux de trésorerie 19
| Métrique | Tendance | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D&A | $4.61B | $4.60B | $4.37B | $4.22B | $4.49B | $4.44B | $4.37B | · | $2.48B | $2.48B | $2.09B | |
| Stock-based Comp | $535M | $540M | $588M | $447M | $484M | $400M | $453M | · | $234M | $222M | $230M | |
| Deferred Tax | $102M | $-572M | $-676M | $-2.03B | $-402M | $-564M | $-649M | · | $-1.42B | $3M | $-234M | |
| Amort. of Intangibles | $2.00B | $2.00B | $1.90B | $1.80B | $2.20B | $2.30B | $2.40B | · | $817M | $795M | $611M | |
| Restructuring | · | · | · | · | · | · | · | · | $215M | · | · | |
| Other Non-cash | $3.63B | $-72M | $804M | $9.41B | $5.79B | $4.41B | $2.04B | · | $93M | · | · | |
| Operating Cash Flow | $10.64B | $9.11B | $13.43B | $16.18B | $18.27B | $15.87B | $12.85B | · | $8.01B | $10.14B | $8.54B | |
| CapEx | $2.83B | $2.78B | $3.03B | $2.73B | $2.52B | $2.44B | $2.46B | · | $1.92B | $2.22B | $2.37B | |
| Investing Cash Flow | $-5.87B | $-7.61B | $-20.89B | $-5.05B | $-5.26B | $-5.53B | $-3.34B | · | $-2.88B | $-2.47B | $-13.42B | |
| Debt Issued | $3.97B | $7.91B | $10.90B | $0 | $987M | $9.96B | $3.74B | · | $0 | $3.46B | $14.80B | |
| Net Debt Issued | $340M | $3.14B | $7.73B | $-4.21B | $-9.27B | $-5.67B | $-4.60B | · | · | $-2.49B | $11.90B | |
| Stock Repurchased | $0 | $3.02B | $2.01B | $3.50B | $0 | $0 | $0 | · | $4.36B | $4.46B | $5.00B | |
| Net Stock Activity | $0 | $-3.02B | $-2.01B | $-3.50B | · | · | $0 | · | $-4.36B | $-4.46B | $-5.00B | |
| Dividends Paid | $3.40B | $3.37B | $3.13B | $2.91B | $2.62B | $2.62B | $2.60B | · | $2.05B | $1.84B | $1.58B | |
| Financing Cash Flow | $-4.94B | $-1.14B | $2.68B | $-10.52B | $-11.36B | $-7.70B | $-7.65B | · | $-6.75B | $-6.76B | $4.88B | |
| Net Change in Cash | $-172M | $359M | $-4.78B | $614M | $1.65B | $2.63B | $1.85B | · | $-1.62B | $912M | $-22M | |
| Taxes Paid | $2.17B | $1.70B | $3.52B | $4.12B | $3.19B | $2.93B | $2.72B | · | $2.91B | $3.06B | $3.27B | |
| Free Cash Flow | $7.81B | $6.33B | $10.39B | $13.45B | $15.74B | $13.43B | $10.39B | · | $6.09B | $7.84B | $6.04B | |
| Levered FCF | · | · | $8.40B | $11.76B | $13.85B | $11.29B | $8.15B | · | $5.24B | $7.18B | $5.52B |
Rentabilité 8
| Métrique | Tendance | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Gross Margin | · | · | · | · | · | · | · | · | 15.4% | 16.3% | 17.3% | |
| Operating Margin | 1.2% | 2.3% | 3.8% | 2.4% | 4.5% | 5.2% | 4.7% | · | 5.1% | 5.8% | 6.2% | |
| Net Margin | 0.44% | 1.2% | 2.3% | 1.3% | 2.7% | 2.7% | 2.6% | · | 3.6% | 3.0% | 3.4% | |
| Pretax Margin | 0.53% | 1.7% | 3.1% | 1.8% | 3.6% | 3.6% | 3.5% | · | 4.5% | 4.9% | 5.6% | |
| EBITDA Margin | 2.3% | 3.5% | 5.1% | 3.7% | 6.1% | 6.8% | 6.4% | · | 6.5% | 5.8% | 6.2% | |
| ROA | 0.70% | 1.8% | 3.5% | 1.8% | 3.4% | 3.2% | 3.0% | · | 7.0% | 5.7% | 6.2% | |
| ROE | 2.4% | 6.1% | 11.3% | 5.7% | 10.9% | 10.8% | 10.8% | · | 17.8% | 14.4% | 13.9% | |
| ROIC | 5.0% | 8.2% | 13.4% | 8.1% | 13.3% | 14.8% | 13.1% | · | 11.8% | 9.9% | 8.9% |
Liquidité et Solvabilité 5
| Métrique | Tendance | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 0.8 | 0.8 | 0.9 | 0.9 | 0.9 | 0.9 | 0.9 | · | 1.0 | 1.2 | 1.3 | |
| Quick Ratio | 0.6 | 0.6 | 0.6 | 0.6 | 0.5 | 0.5 | 0.5 | · | 0.5 | 0.6 | 0.6 | |
| Debt / Equity | 0.0 | 0.0 | 0.0 | · | · | · | 0.1 | · | 0.7 | 0.7 | 0.7 | |
| LT Debt / Equity | · | · | · | · | · | · | · | · | 0.6 | 0.7 | 0.7 | |
| Interest Coverage | · | · | 5.2 | 3.4 | 5.3 | 4.8 | 3.9 | · | 9.0 | 9.6 | 11.0 |
Efficacité 3
| Métrique | Tendance | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 1.6 | 1.5 | 1.5 | 1.4 | 1.3 | 1.2 | 1.2 | · | 1.9 | 1.9 | 1.8 | |
| Inventory Turnover | 11.8 | 11.4 | 11.7 | 10.7 | 9.7 | 9.1 | 9.3 | · | 10.4 | 10.3 | 9.8 | |
| Receivables Turnover | 10.5 | 10.4 | 11.4 | 12.5 | 12.7 | 13.0 | 13.8 | · | 14.6 | 14.8 | 14.2 |
Taux de croissance 10
| Métrique | Tendance | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY | 7.8% | 4.2% | 10.9% | 10.4% | 8.7% | · | · | · | · | · | · | |
| Revenue CAGR 3Y | 7.6% | 8.5% | 10.0% | · | · | · | · | · | · | · | · | |
| Revenue CAGR 5Y | 8.4% | · | · | · | · | · | · | · | · | · | · | |
| EPS YoY | -62.0% | -43.4% | 98.5% | -45.9% | 10.3% | · | · | · | · | · | · | |
| EPS CAGR 3Y | -24.7% | -15.3% | 5.8% | · | · | · | · | · | · | · | · | |
| EPS CAGR 5Y | -23.9% | · | · | · | · | · | · | · | · | · | · | |
| Net Income YoY | -61.7% | -44.7% | 93.5% | -46.1% | 11.5% | · | · | · | · | · | · | |
| Net Income CAGR 3Y | -25.7% | -16.8% | 5.1% | · | · | · | · | · | · | · | · | |
| Net Income CAGR 5Y | -24.4% | · | · | · | · | · | · | · | · | · | · | |
| Dividend CAGR 5Y | 5.3% | · | · | · | · | · | · | · | · | · | · |
Valorisation (TTM) 16
| Métrique | Tendance | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $402.07B | $372.81B | $357.78B | $322.47B | $292.11B | $268.71B | $256.78B | · | $184.79B | $177.55B | $153.29B | |
| Net Income TTM | $1.77B | $4.61B | $8.34B | $4.31B | $8.00B | $7.18B | $6.63B | · | $6.62B | $5.32B | $5.24B | |
| Market Cap | $100.87B | $56.56B | $101.70B | $121.15B | $136.38B | $89.47B | $96.73B | · | $73.52B | $83.72B | $107.64B | |
| Enterprise Value | $90.27B | $47.69B | $90.45B | · | · | · | $92.45B | · | $98.71B | $107.80B | $132.56B | |
| P/E | 57.1 | 12.3 | 12.2 | 28.6 | 17.1 | 12.5 | 14.6 | · | 11.3 | 16.1 | 21.1 | |
| P/S | 0.3 | 0.2 | 0.3 | 0.4 | 0.5 | 0.3 | 0.4 | · | 0.4 | 0.5 | 0.7 | |
| P/B | 1.3 | 0.7 | 1.3 | 1.7 | 1.8 | 1.3 | 1.5 | · | 2.0 | 2.3 | 2.9 | |
| P / Cash Flow | 9.5 | 6.2 | 7.6 | 7.5 | 7.5 | 5.6 | 7.5 | · | 9.2 | 8.3 | 12.8 | |
| P / FCF | 12.9 | 8.9 | 9.8 | 9.0 | 8.7 | 6.7 | 9.3 | · | 12.1 | 10.7 | 17.8 | |
| EV / EBITDA | 9.7 | 3.6 | 5.0 | · | · | · | 5.7 | · | 8.2 | 10.4 | 14.0 | |
| EV / FCF | 11.6 | 7.5 | 8.7 | · | · | · | 8.9 | · | 16.2 | 13.7 | 21.9 | |
| EV / Revenue | 0.2 | 0.1 | 0.3 | · | · | · | 0.4 | · | 0.5 | 0.6 | 0.9 | |
| Dividend Yield | 3.4% | 6.0% | 3.1% | 2.4% | 1.9% | 2.9% | 2.7% | · | 2.8% | 2.2% | 1.5% | |
| Earnings Yield | 1.8% | 8.2% | 8.2% | 3.5% | 5.8% | 8.0% | 6.8% | · | 8.9% | 6.2% | 4.7% | |
| Payout Ratio | 192.1% | 73.1% | 37.5% | 70.1% | 33.2% | 36.5% | 39.2% | · | 30.9% | 34.6% | 30.1% | |
| Annual Payout | $3.40B | $3.37B | $3.13B | $2.91B | $2.62B | $2.62B | $2.60B | · | $2.05B | $1.84B | $1.58B |
Compte de résultat 14
| Métrique | Tendance | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $106.10B | $100.43B | $105.69B | $102.87B | $98.92B | $94.59B | $97.71B | $95.43B | $91.23B | $88.44B | $93.81B | $89.76B | $88.92B | $85.28B | $83.85B | $81.16B | |
| Cost of Revenue | $58.86B | $55.44B | $59.06B | $57.05B | $54.01B | $51.06B | $55.27B | $52.95B | $50.00B | $48.07B | $57.42B | $54.69B | $53.54B | $51.45B | $51.73B | $50.37B | |
| Operating Expenses | $101.39B | $95.75B | $103.58B | $106.08B | $96.53B | $91.21B | $95.34B | $94.60B | $88.19B | $86.17B | $90.44B | $86.07B | $85.69B | $81.83B | $80.19B | $85.08B | |
| Operating Income | $4.70B | $4.68B | $2.11B | $-3.21B | $2.38B | $3.37B | $2.37B | $832M | $3.04B | $2.27B | $3.37B | $3.69B | $3.23B | $3.45B | $3.66B | $-3.92B | |
| Interest Expense | · | · | · | · | · | · | · | · | · | $716M | · | $693M | $686M | $589M | · | $566M | |
| Other Non-op | $31M | $32M | $29M | $26M | $29M | $28M | $25M | $25M | $24M | $25M | $22M | $22M | $22M | $22M | $43M | $41M | |
| Pretax Income | $3.98B | $3.94B | $1.35B | $-3.48B | $1.65B | $2.62B | $2.13B | $105M | $2.34B | $1.58B | $2.71B | $3.02B | $2.57B | $2.88B | $3.15B | $-4.44B | |
| Income Tax | $982M | $981M | $-1.57B | $508M | $634M | $835M | $503M | $34M | $569M | $456M | $658M | $754M | $656M | $737M | $818M | $-1.04B | |
| Net Income | $2.98B | $2.94B | $2.94B | $-3.98B | $1.02B | $1.78B | $1.64B | $87M | $1.77B | $1.11B | $2.05B | $2.26B | $1.90B | $2.14B | $2.33B | $-3.41B | |
| EPS (Basic) | $2.33 | $2.31 | $2.31 | $-3.13 | $0.81 | $1.41 | $1.31 | $0.07 | $1.41 | $0.88 | $1.59 | $1.76 | $1.48 | $1.66 | $1.78 | $-2.59 | |
| EPS (Diluted) | $2.31 | $2.30 | $2.31 | $-3.13 | $0.80 | $1.41 | $1.30 | $0.07 | $1.41 | $0.88 | $1.59 | $1.75 | $1.48 | $1.65 | $1.79 | $-2.59 | |
| Shares (Basic) | 1,279,000,000 | 1,273,000,000 | -2,529,000,000 | 1,269,000,000 | 1,266,000,000 | 1,261,000,000 | -2,516,000,000 | 1,259,000,000 | 1,256,000,000 | 1,260,000,000 | -2,568,000,000 | 1,287,000,000 | 1,283,000,000 | 1,283,000,000 | -2,628,000,000 | 1,315,000,000 | |
| Shares (Diluted) | 1,287,000,000 | 1,279,000,000 | -2,532,000,000 | 1,269,000,000 | 1,270,000,000 | 1,264,000,000 | -2,523,000,000 | 1,259,000,000 | 1,259,000,000 | 1,267,000,000 | -2,578,000,000 | 1,290,000,000 | 1,287,000,000 | 1,291,000,000 | -2,641,000,000 | 1,315,000,000 | |
| EBITDA | $5.83B | $5.79B | · | $-2.07B | $3.55B | $4.53B | · | $832M | $3.04B | $3.41B | · | $3.69B | $3.23B | $4.45B | · | $-3.93B |
Bilan 26
| Métrique | Tendance | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $11.33B | $9.54B | $8.45B | $9.10B | $11.79B | $10.08B | $8.59B | $6.88B | $12.51B | $9.80B | $8.20B | $13.04B | $13.81B | $14.62B | $12.95B | $17.20B | |
| Short-term Investments | $2.63B | $2.26B | $2.15B | $2.13B | $2.39B | $2.58B | $2.41B | $2.81B | $3.75B | $3.29B | · | $3.15B | $3.08B | $3.10B | · | $2.79B | |
| Receivables | $40.31B | $40.99B | $39.78B | $43.86B | $40.65B | $39.62B | $36.47B | $36.18B | $32.38B | $32.22B | · | $32.93B | $29.55B | $28.33B | · | $26.32B | |
| Inventory | $17.62B | $17.77B | $19.25B | $18.96B | $17.45B | $17.39B | $18.11B | $17.65B | $16.07B | $16.35B | · | $17.95B | $17.29B | $18.26B | · | $18.06B | |
| Other Current Assets | $3.46B | $4.25B | $5.09B | $3.06B | $3.38B | $3.53B | $3.08B | $3.83B | $5.24B | $5.82B | · | $3.07B | $3.41B | $3.77B | · | $2.48B | |
| Current Assets | $75.35B | $74.82B | $74.71B | $77.11B | $75.65B | $73.19B | $68.64B | $67.34B | $69.95B | $67.47B | · | $70.14B | $67.76B | $68.71B | · | $68.34B | |
| PP&E (Net) | · | · | · | · | · | · | · | · | · | · | · | $13.02B | $13.00B | $12.87B | · | $12.63B | |
| Goodwill | $85.48B | $85.48B | $85.48B | $85.48B | $91.20B | $91.20B | $91.27B | $91.27B | $91.27B | $91.27B | $91.27B | $91.26B | $91.26B | $84.06B | $78.15B | $78.09B | |
| Intangibles | $24.64B | $25.07B | $25.51B | $25.98B | $26.22B | $26.57B | $27.32B | $27.82B | $28.31B | $28.77B | · | $29.62B | $30.12B | $26.37B | · | $25.16B | |
| Other Non-current Assets | $7.43B | $7.42B | $5.12B | $5.16B | $5.21B | $5.23B | $4.79B | $4.76B | $4.80B | $4.80B | · | $4.83B | $4.85B | $4.82B | · | $4.85B | |
| Total Assets | $253.77B | $252.97B | $253.54B | $255.33B | $258.34B | $255.59B | $253.22B | $252.43B | $252.48B | $249.74B | · | $251.31B | $250.07B | $239.33B | · | $231.21B | |
| Accrued Liabilities | $22.48B | $22.26B | $22.39B | $23.41B | $23.10B | $22.37B | $20.81B | $20.17B | $21.16B | $22.35B | · | $22.57B | $22.83B | $21.52B | · | $19.42B | |
| Short-term Debt | · | · | $0 | $1.25B | $3.04B | $1.26B | $2.12B | $800M | $0 | $2.72B | · | · | $1.00B | · | · | · | |
| Current Liabilities | $87.04B | $86.41B | $88.69B | $92.69B | $94.16B | $88.96B | $84.61B | $84.63B | $81.39B | $83.32B | · | $81.55B | $79.21B | $75.05B | · | $72.41B | |
| Capital Leases | $12.98B | $13.33B | $13.64B | $14.01B | $14.33B | $14.59B | $14.90B | $15.26B | $15.54B | $15.74B | · | $16.44B | $16.61B | $16.57B | · | $17.17B | |
| Deferred Tax | $3.77B | $3.77B | $3.83B | $3.55B | $3.60B | $3.66B | $3.81B | $3.63B | $4.05B | $4.18B | · | $4.25B | $4.59B | $4.09B | · | $3.51B | |
| Other Non-current Liabilities | $6.11B | $6.71B | $4.78B | $4.76B | $4.78B | $5.42B | $5.43B | $5.48B | $5.53B | $6.21B | · | $6.24B | $6.32B | $6.67B | · | $6.77B | |
| Total Liabilities | $173.87B | $175.34B | $178.16B | $182.22B | $180.79B | $178.47B | $177.49B | $177.32B | $177.37B | $175.59B | · | $176.80B | $177.07B | $167.75B | · | $160.20B | |
| Total Debt | · | · | · | $1.25B | $3.04B | $1.26B | · | $800M | $0 | $2.72B | · | · | $1.00B | · | · | · | |
| Common Stock | · | · | · | $18M | $18M | $18M | · | $18M | $18M | $18M | · | $18M | $18M | $18M | $18M | $18M | |
| Retained Earnings | $65.40B | $63.28B | $61.20B | $59.11B | $63.94B | $63.77B | $62.84B | $62.04B | $62.80B | $61.87B | · | $60.34B | $58.87B | $57.75B | · | $54.57B | |
| Treasury Stock | $36.85B | $36.71B | $36.79B | $36.78B | $36.85B | $36.73B | $36.82B | $36.81B | $36.92B | $36.77B | · | $33.83B | $33.93B | $33.80B | · | $30.33B | |
| AOCI | $188M | $201M | $406M | $416M | $272M | $59M | $-120M | $209M | $-319M | $-341M | · | $-1.00B | $-858M | $-875M | · | $-1.61B | |
| Stockholders' Equity | $79.70B | $77.46B | $75.21B | $72.93B | $77.38B | $76.93B | $75.56B | $74.94B | $74.93B | $73.97B | · | $74.34B | $72.73B | $71.38B | · | $70.68B | |
| Liabilities + Equity | $253.77B | $252.97B | $253.54B | $255.33B | $258.34B | $255.59B | $253.22B | $252.43B | $252.48B | $249.74B | · | $251.31B | $250.07B | $239.33B | · | $231.21B | |
| Shares Outstanding | 1,278,000,000 | 1,273,000,000 | 1,271,000,000 | 1,270,000,000 | 1,267,000,000 | 1,262,000,000 | 1,260,000,000 | 1,258,000,000 | 1,256,000,000 | 1,252,000,000 | · | 1,287,000,000 | 1,282,000,000 | 1,279,000,000 | · | 1,315,000,000 |
Flux de trésorerie 17
| Métrique | Tendance | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D&A | $1.13B | $1.11B | $1.15B | $1.13B | $1.17B | $1.15B | $1.15B | $1.16B | $1.15B | $1.14B | $1.13B | $1.13B | $1.10B | $1.00B | $1.04B | $1.04B | |
| Stock-based Comp | $176M | $266M | $135M | $138M | $136M | $126M | $137M | $133M | $133M | $137M | $127M | $154M | $204M | $103M | $106M | $105M | |
| Amort. of Intangibles | $431M | $442M | $507M | $500M | $494M | $499M | $478M | $507M | $507M | $508M | $504M | $509M | $485M | $402M | $420M | $458M | |
| Other Non-cash | · | $-75M | · | · | · | $1.50B | · | · | · | $2.52B | · | · | · | $4.20B | · | · | |
| Operating Cash Flow | $6.34B | $4.25B | $3.39B | $796M | $1.90B | $4.56B | $1.86B | $-745M | $3.09B | $4.90B | $-2.64B | $2.72B | $5.91B | $7.44B | $-1.95B | $9.12B | |
| CapEx | $691M | $849M | $784M | $698M | $607M | $743M | $768M | $670M | $638M | $705M | $911M | $545M | $591M | $984M | $688M | $580M | |
| Investing Cash Flow | $-1.88B | $-874M | $-2.00B | $-2.09B | $-1.02B | $-762M | $-547M | $-3.35B | $-1.62B | $-2.09B | $-1.24B | $-771M | $-10.36B | $-8.51B | $-119M | $-805M | |
| Debt Issued | · | · | $0 | $3.97B | · | · | $2.95B | $0 | $4.96B | $0 | $0 | $0 | $4.95B | $5.95B | $0 | $0 | |
| Net Debt Issued | · | $-1.52B | · | · | · | $-743M | · | · | · | $-18M | · | · | · | $5.59B | · | · | |
| Stock Repurchased | · | · | $0 | $0 | $0 | $0 | $0 | $-1M | $-3M | $3.03B | $-1M | $-3M | $-2M | $2.02B | $1.50B | $0 | |
| Net Stock Activity | · | · | · | · | · | $0 | · | · | · | $-3.03B | · | · | · | $-2.02B | · | · | |
| Dividends Paid | $878M | $847M | $845M | $846M | $866M | $840M | $838M | $837M | $858M | $840M | $779M | $779M | $795M | $779M | $719M | $726M | |
| Financing Cash Flow | $-2.69B | $-2.32B | $-2.03B | $-1.38B | $806M | $-2.33B | $431M | $-1.59B | $1.25B | $-1.23B | $-972M | $-2.70B | $3.63B | $2.73B | $-2.19B | $-3.22B | |
| Net Change in Cash | $1.77B | $1.06B | $-640M | $-2.67B | $1.68B | $1.46B | $1.74B | $-5.68B | $2.71B | $1.58B | $-4.85B | $-752M | $-828M | $1.65B | $-4.26B | $5.10B | |
| Taxes Paid | $374M | $-337M | $998M | $305M | $725M | $138M | $274M | $700M | $666M | $63M | $908M | $837M | $1.70B | $75M | $1.05B | $1.18B | |
| Free Cash Flow | · | $3.40B | · | · | · | $3.81B | · | · | · | $4.20B | · | · | · | $6.45B | · | · | |
| Levered FCF | · | · | · | · | · | · | · | · | · | $3.69B | · | · | · | $6.02B | · | · |
Rentabilité 7
| Métrique | Tendance | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Margin | 4.4% | 4.7% | · | -3.1% | 2.4% | 3.6% | · | 0.87% | 3.3% | 2.6% | · | 4.1% | 3.6% | 4.0% | · | -4.8% | |
| Net Margin | 2.8% | 2.9% | · | -3.9% | 1.0% | 1.9% | · | 0.09% | 1.9% | 1.3% | · | 2.5% | 2.1% | 2.5% | · | -4.2% | |
| Pretax Margin | 3.8% | 3.9% | · | -3.4% | 1.7% | 2.8% | · | 0.11% | 2.6% | 1.8% | · | 3.4% | 2.9% | 3.4% | · | -5.5% | |
| EBITDA Margin | 5.5% | 5.8% | · | -2.0% | 3.6% | 4.8% | · | 0.87% | 3.3% | 3.9% | · | 4.1% | 3.6% | 5.2% | · | -4.8% | |
| ROA | 1.2% | 1.2% | · | -1.6% | 0.40% | 0.70% | · | 0.03% | 0.70% | 0.46% | · | 0.94% | 0.79% | 0.90% | · | -1.5% | |
| ROE | 3.8% | 3.8% | · | -5.4% | 1.3% | 2.4% | · | 0.12% | 2.4% | 1.5% | · | 3.1% | 2.6% | 2.9% | · | -4.7% | |
| ROIC | 4.4% | 4.5% | · | -5.0% | 1.8% | 2.9% | · | 0.74% | 3.1% | 2.1% | · | 3.7% | 3.3% | 3.6% | · | -4.2% |
Liquidité et Solvabilité 4
| Métrique | Tendance | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 0.9 | 0.9 | · | 0.8 | 0.8 | 0.8 | · | 0.8 | 0.9 | 0.8 | · | 0.9 | 0.9 | 0.9 | · | 0.9 | |
| Quick Ratio | 0.6 | 0.6 | · | 0.6 | 0.6 | 0.6 | · | 0.5 | 0.6 | 0.5 | · | 0.6 | 0.6 | 0.6 | · | 0.6 | |
| Debt / Equity | · | · | · | 0.0 | 0.0 | 0.0 | · | 0.0 | 0.0 | 0.0 | · | · | 0.0 | · | · | · | |
| Interest Coverage | · | · | · | · | · | · | · | · | · | 3.2 | · | 5.3 | 4.7 | 5.9 | · | -6.9 |
Efficacité 3
| Métrique | Tendance | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 0.4 | 0.4 | · | 0.4 | 0.4 | 0.4 | · | 0.4 | 0.4 | 0.4 | · | 0.4 | 0.4 | 0.4 | · | 0.3 | |
| Inventory Turnover | 3.4 | 3.2 | · | 3.1 | 3.2 | 3.0 | · | 3.0 | 3.0 | 2.8 | · | 3.0 | 3.1 | 2.8 | · | 2.8 | |
| Receivables Turnover | 2.6 | 2.5 | · | 2.6 | 2.7 | 2.6 | · | 2.8 | 2.9 | 2.9 | · | 3.0 | 3.1 | 3.1 | · | 3.1 |
Valorisation (TTM) 14
| Métrique | Tendance | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $408.31B | $396.80B | · | $391.80B | $380.17B | $369.69B | · | $364.86B | $358.36B | $352.40B | · | $345.12B | $335.99B | $323.90B | · | $312.42B | |
| Net Income TTM | $2.97B | $1.77B | · | $-1.09B | $4.66B | $4.75B | · | $5.23B | $7.04B | $7.41B | · | $2.89B | $3.66B | $4.11B | · | $3.58B | |
| Market Cap | $132.21B | $91.43B | · | $95.75B | $87.40B | $85.50B | · | $79.10B | $74.18B | $99.86B | · | $89.86B | $88.62B | $95.04B | · | $125.41B | |
| Enterprise Value | · | · | · | $85.76B | $76.26B | $74.11B | · | $70.22B | $57.92B | $89.49B | · | · | $72.74B | · | · | · | |
| P/E | 45.4 | 52.0 | · | -88.7 | 18.7 | 18.0 | · | 15.3 | 10.7 | 13.8 | · | 30.5 | 24.4 | 23.8 | · | 35.7 | |
| P/S | 0.3 | 0.2 | · | 0.2 | 0.2 | 0.2 | · | 0.2 | 0.2 | 0.3 | · | 0.3 | 0.3 | 0.3 | · | 0.4 | |
| P/B | 1.7 | 1.2 | · | 1.3 | 1.1 | 1.1 | · | 1.1 | 1.0 | 1.4 | · | 1.2 | 1.2 | 1.3 | · | 1.8 | |
| P / Cash Flow | · | 21.5 | · | · | · | 18.8 | · | · | · | 20.4 | · | · | · | 12.8 | · | · | |
| P / FCF | · | 26.9 | · | · | · | 22.4 | · | · | · | 23.8 | · | · | · | 14.7 | · | · | |
| EV / EBITDA | · | · | · | -41.4 | 21.5 | 16.4 | · | 84.4 | 19.0 | 26.3 | · | · | 22.5 | · | · | · | |
| EV / FCF | · | · | · | · | · | 19.4 | · | · | · | 21.3 | · | · | · | · | · | · | |
| EV / Revenue | · | · | · | 0.2 | 0.2 | 0.2 | · | 0.2 | 0.2 | 0.3 | · | · | 0.2 | · | · | · | |
| Earnings Yield | 2.2% | 1.9% | · | -1.1% | 5.3% | 5.6% | · | 6.5% | 9.3% | 7.2% | · | 3.3% | 4.1% | 4.2% | · | 2.8% | |
| Payout Ratio | · | 28.8% | · | · | · | 47.2% | · | · | · | 75.5% | · | · | · | 36.5% | · | · |
États financiers Compte de résultat, bilan, flux de trésorerie — annuel, sur les 5 dernières années
Compte de résultat
| 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | |
|---|---|---|---|---|---|
| Revenu | $402.07B | $372.81B | $357.78B | $322.47B | $292.11B |
| Marge d'exploitation % | 1.2% | 2.3% | 3.8% | 2.4% | 4.5% |
| Résultat net | $1.77B | $4.61B | $8.34B | $4.31B | $8.00B |
| BPA dilué | $1.39 | $3.66 | $6.47 | $3.26 | $6.02 |
Bilan
| 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | |
|---|---|---|---|---|---|
| Dette / Capitaux propres | 0.0 | 0.0 | 0.0 | — | — |
| Ratio de liquidité | 0.8 | 0.8 | 0.9 | 0.9 | 0.9 |
| Ratio de liquidité réduite | 0.6 | 0.6 | 0.6 | 0.6 | 0.5 |
Flux de trésorerie
| 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | |
|---|---|---|---|---|---|
| Flux de trésorerie libre | $7.81B | $6.33B | $10.39B | $13.45B | $15.74B |
Dernières actualités Actualités récentes mentionnant cette entreprise
- As Americans go direct with GLP-1 prescriptions, Walmart, Costco, Amazon will be big weight-loss winners
- What A Patient Holder Is Really Paying For CVS Health Stock
- Mise à jour du marché : CVS, ETN, KMB, KO, PSX
- Jim Cramer sur CVS : « Je dirais que c'est moins cher »
- Pourquoi l'action CVS a bondi mercredi
- Jim Cramer fait une affirmation majeure concernant CVS Corporation (CVS)
Signaux de trading Signaux d'achat/vente récents avec prix d'entrée et ratio risque/récompense
Mes métriques Votre watchlist personnelle — lignes sélectionnées de Fondamentaux Complets
📊
Choisissez les indicateurs qui vous importent — cliquez sur le ➕ à côté de n'importe quelle ligne dans Fondamentaux Complets ci-dessus.
Votre sélection est enregistrée et vous suit sur tous les tickers.
Détenteurs institutionnels (13F) 2 292 déclarants · $77.0B total · Au 30 juin 2026
Institutions qui déclarent détenir cette action dans leur Formulaire SEC 13F trimestriel. Uniquement les positions longues ; un même déclarant peut apparaître deux fois pour des jambes d'options distinctes. Les jambes put/call compensatoires importantes reflètent généralement la tenue de marché ou un inventaire couvert, pas une conviction directionnelle.
Activité institutionnelle — Q2 2026 vs trimestre précédent
| Nouvelles positions | Positions clôturées | Augmenté | Diminué | Variation nette des actions |
|---|---|---|---|---|
| 312 (+119 vs T. préc.) | 93 (-95 vs T. préc.) | 797 (+96 vs T. préc.) | 722 (-51 vs T. préc.) | +62.2M |
Comparé à Q1 2026. Les dépôts de formulaire 13F de la SEC sont dus dans les 45 jours suivant la fin du trimestre, plus une courte période tampon pour les déposants tardifs — les trimestres encore dans cette fenêtre sont ignorés au profit de la paire la plus récente entièrement déclarée.
| Institution | Valeur | Actions | % de 13F suivies | Type |
|---|---|---|---|---|
| VANGUARD CAPITAL MANAGEMENT LLC | $8 618 974 924 | 83 315 369 | 11,20% | Actions |
| Capital World Investors | $7 753 834 783 | 74 951 955 | 10,07% | Actions |
| STATE STREET CORP | $6 236 318 558 | 60 283 408 | 8,10% | Actions |
| Dodge & Cox | $5 173 820 539 | 50 012 765 | 6,72% | Actions |
| WELLINGTON MANAGEMENT GROUP LLP | $3 266 370 439 | 31 574 388 | 4,24% | Actions |
| VANGUARD PORTFOLIO MANAGEMENT LLC | $2 755 624 444 | 26 637 259 | 3,58% | Actions |
| GEODE CAPITAL MANAGEMENT, LLC | $2 646 473 316 | 25 714 722 | 3,44% | Actions |
| Capital Research Global Investors | $2 516 851 376 | 24 329 151 | 3,27% | Actions |
| NORGES BANK | $1 866 126 481 | 18 038 922 | 2,42% | Actions |
| FMR LLC | $1 684 924 609 | 16 287 333 | 2,19% | Actions |
| Capital International Investors | $1 591 868 430 | 15 387 600 | 2,07% | Actions |
| Davis Selected Advisers | $1 227 594 458 | 11 865 916 | 1,59% | Actions |
| Clearbridge Investments, LLC | $878 119 687 | 8 488 349 | 1,14% | Actions |
| GQG Partners LLC | $822 989 370 | 7 955 411 | 1,07% | Actions |
| AMERIPRISE FINANCIAL INC | $761 355 564 | 7 357 966 | 0,99% | Actions |
| VANGUARD FIDUCIARY TRUST CO | $741 242 940 | 7 165 229 | 0,96% | Actions |
| DIMENSIONAL FUND ADVISORS LP | $643 180 166 | 6 217 304 | 0,84% | Actions |
| ARROWSTREET CAPITAL, LIMITED PARTNERSHIP | $524 415 257 | 5 069 263 | 0,68% | Actions |
| GLENVIEW CAPITAL MANAGEMENT, LLC | $499 125 457 | 4 824 799 | 0,65% | Actions |
| CITADEL ADVISORS LLC | $493 765 609 | 4 772 988 | 0,64% | Actions |
| VIKING GLOBAL INVESTORS LP | $378 974 695 | 3 663 361 | 0,49% | Actions |
| Swiss National Bank | $371 195 152 | 3 588 160 | 0,48% | Actions |
| BlackRock, Inc. | $364 982 048 | 3 528 101 | 0,47% | Actions |
| RAYMOND JAMES FINANCIAL INC | $354 997 941 | 3 431 590 | 0,46% | Actions |
| National Pension Service | $352 166 145 | 3 404 216 | 0,46% | Actions |
| ROYAL BANK OF CANADA | $338 495 000 | 3 272 060 | 0,44% | Actions |
| Mitsubishi UFJ Asset Management Co., Ltd. | $322 653 390 | 3 118 927 | 0,42% | Actions |
| GOLDMAN SACHS GROUP INC | $319 964 422 | 3 092 938 | 0,42% | Actions |
| Legal & General Group Plc | $315 302 980 | 3 047 878 | 0,41% | Actions |
| Holocene Advisors, LP | $310 524 210 | 3 001 684 | 0,40% | Actions |
| ENVESTNET ASSET MANAGEMENT INC | $300 309 006 | 2 902 944 | 0,39% | Actions |
| CITADEL ADVISORS LLC | $299 591 200 | 2 896 000 | 0,39% | Option d'achat |
| Sumitomo Mitsui Trust Group, Inc. | $298 855 050 | 2 888 884 | 0,39% | Actions |
| Vanguard Global Advisers, LLC | $295 578 375 | 2 857 210 | 0,38% | Actions |
| VANGUARD ASSET MANAGEMENT, Ltd | $295 497 373 | 2 856 427 | 0,38% | Actions |
| FAIRFAX FINANCIAL HOLDINGS LTD/ CAN | $280 502 160 | 2 712 000 | 0,36% | Actions |
| CITADEL ADVISORS LLC | $267 076 865 | 2 581 700 | 0,35% | Option de vente |
| BNP PARIBAS FINANCIAL MARKETS | $261 748 880 | 2 530 197 | 0,34% | Actions |
| BANK OF AMERICA CORP /DE/ | $249 417 276 | 2 410 993 | 0,32% | Actions |
| PRIMECAP MANAGEMENT CO/CA/ | $246 778 944 | 2 385 490 | 0,32% | Actions |
| RHUMBLINE ADVISERS | $246 744 475 | 2 385 158 | 0,32% | Actions |
| FRANKLIN RESOURCES INC | $238 592 528 | 2 306 356 | 0,31% | Actions |
| California Public Employees Retirement System | $233 879 967 | 2 260 802 | 0,30% | Actions |
| ALLIANCEBERNSTEIN L.P. | $232 194 060 | 3 233 000 | 0,30% | Actions |
| JANE STREET GROUP, LLC | $231 055 575 | 2 233 500 | 0,30% | Option de vente |
| CANADA PENSION PLAN INVESTMENT BOARD | $230 615 292 | 2 229 244 | 0,30% | Actions |
| Canoe Financial LP | $226 952 024 | 2 193 833 | 0,29% | Actions |
| MILLENNIUM MANAGEMENT LLC | $223 951 974 | 2 164 833 | 0,29% | Actions |
| VANGUARD GROUP INC | $222 935 255 | 2 809 164 | 0,29% | Actions |
| UBS Group AG | $221 527 830 | 2 141 400 | 0,29% | Option d'achat |
| Brandywine Global Investment Management, LLC | $216 103 153 | 2 723 074 | 0,28% | Actions |
| Robeco Institutional Asset Management B.V. | $207 806 227 | 2 008 760 | 0,27% | Actions |
| Zurcher Kantonalbank (Zurich Cantonalbank) | $205 293 939 | 1 984 475 | 0,27% | Actions |
| Point72 Asset Management, L.P. | $202 868 760 | 1 961 032 | 0,26% | Actions |
| JANUS HENDERSON GROUP PLC | $200 732 734 | 2 794 942 | 0,26% | Actions |
| JANE STREET GROUP, LLC | $190 306 620 | 1 839 600 | 0,25% | Option d'achat |
| JONES FINANCIAL COMPANIES LLLP | $186 577 346 | 1 788 167 | 0,24% | Actions |
| Assenagon Asset Management S.A. | $183 757 718 | 1 776 295 | 0,24% | Actions |
| MACKENZIE FINANCIAL CORP | $177 786 480 | 1 718 574 | 0,23% | Actions |
| Hamlin Capital Management, LLC | $177 686 548 | 1 717 608 | 0,23% | Actions |
| Alyeska Investment Group, L.P. | $174 358 768 | 1 685 440 | 0,23% | Actions |
| ADAGE CAPITAL PARTNERS GP, L.L.C. | $169 576 171 | 1 639 209 | 0,22% | Actions |
| LPL Financial LLC | $160 912 185 | 1 555 458 | 0,21% | Actions |
| PRUDENTIAL FINANCIAL INC | $156 319 985 | 1 511 068 | 0,20% | Actions |
| GOLDMAN SACHS GROUP INC | $153 033 585 | 1 479 300 | 0,20% | Option d'achat |
| Quantinno Capital Management LP | $150 197 267 | 1 451 882 | 0,20% | Actions |
| PRINCIPAL FINANCIAL GROUP INC | $149 812 359 | 1 448 162 | 0,19% | Actions |
| NEW YORK STATE COMMON RETIREMENT FUND | $146 277 266 | 1 413 990 | 0,19% | Actions |
| VICTORY CAPITAL MANAGEMENT INC | $143 800 879 | 1 390 052 | 0,19% | Actions |
| PANAGORA ASSET MANAGEMENT INC | $143 310 113 | 1 385 308 | 0,19% | Actions |
| CALIFORNIA STATE TEACHERS RETIREMENT SYSTEM | $135 669 704 | 1 889 024 | 0,18% | Actions |
| MANUFACTURERS LIFE INSURANCE COMPANY, THE | $133 185 771 | 1 287 441 | 0,17% | Actions |
| BARCLAYS PLC | $130 962 631 | 1 265 951 | 0,17% | Actions |
| UBS Group AG | $130 742 593 | 1 263 824 | 0,17% | Actions |
| MACQUARIE GROUP LTD | $130 222 860 | 1 258 800 | 0,17% | Actions |
| Patient Capital Management, LLC | $127 813 106 | 1 235 505 | 0,17% | Actions |
| NOMURA ASSET MANAGEMENT INTERNATIONAL INC. | $125 407 000 | 1 212 248 | 0,16% | Actions |
| Maple Rock Capital Partners Inc. | $123 932 686 | 1 197 996 | 0,16% | Actions |
| BANK OF MONTREAL /CAN/ | $120 915 774 | 1 168 833 | 0,16% | Actions |
| Qube Research & Technologies Ltd | $118 745 083 | 1 147 850 | 0,15% | Actions |
| TD Asset Management Inc | $117 174 298 | 1 132 666 | 0,15% | Actions |
| SCHRODER INVESTMENT MANAGEMENT GROUP | $114 781 970 | 1 108 148 | 0,15% | Actions |
| HEALTHCARE OF ONTARIO PENSION PLAN TRUST FUND | $114 360 975 | 1 105 471 | 0,15% | Actions |
| AVIVA PLC | $113 872 588 | 1 100 750 | 0,15% | Actions |
| Integral Health Asset Management, LLC | $113 795 000 | 1 100 000 | 0,15% | Actions |
| LETKO, BROSSEAU & ASSOCIATES INC | $113 305 164 | 1 095 265 | 0,15% | Actions |
| TRUIST FINANCIAL CORP | $112 799 640 | 1 090 378 | 0,15% | Actions |
| Woodline Partners LP | $112 125 214 | 1 083 859 | 0,15% | Actions |
| STATE BOARD OF ADMINISTRATION OF FLORIDA RETIREMENT SYSTEM | $111 580 653 | 1 078 595 | 0,14% | Actions |
| STOREBRAND ASSET MANAGEMENT AS | $111 494 582 | 1 077 763 | 0,14% | Actions |
| NORDEA INVESTMENT MANAGEMENT AB | $110 986 994 | 1 076 081 | 0,14% | Actions |
| BANK OF NOVA SCOTIA | $103 790 874 | 1 003 295 | 0,13% | Actions |
| Capital International, Inc./CA/ | $102 952 716 | 995 193 | 0,13% | Actions |
| Universal- Beteiligungs- und Servicegesellschaft mbH | $100 146 711 | 970 080 | 0,13% | Actions |
| Walleye Trading LLC | $98 691 300 | 954 000 | 0,13% | Option d'achat |
| Walleye Trading LLC | $98 049 910 | 947 800 | 0,13% | Option de vente |
| Korea Investment CORP | $97 590 385 | 943 358 | 0,13% | Actions |
| JENNISON ASSOCIATES LLC | $97 539 798 | 942 869 | 0,13% | Actions |
| SEB Asset Management AB | $96 760 081 | 935 333 | 0,13% | Actions |
| WORLDQUANT MILLENNIUM ADVISORS LLC | $91 910 670 | 888 455 | 0,12% | Actions |
Initiés de la société 86 initiés · 48 dirigeants · 41 administrateurs
| Dirigeant | Rôle | Dernière activité | Actions détenues | Achats 12m | Ventes 12m | Net 12m |
|---|---|---|---|---|---|---|
| David J. Joyner | President, CEO and Chair | 1 avril 2026 F | 70 349 | 0 | 0 | $0 |
| Karen S Lynch | President and CEO | 1 avril 2024 A | 74 687 | 0 | 0 | $0 |
| Brian Newman | EVP, Chief Financial Officer | 31 mai 2026 F | 3 008 | 0 | 0 | $0 |
| Thomas F. Cowhey | EVP and CFO | 1 avril 2025 A | 41 109 | 0 | 0 | $0 |
| Shawn M Guertin | EVP & Chief Financial Officer | 1 avril 2023 A | 34 706 | 0 | 0 | $0 |
| Eva C Boratto | EVP & CFO | 4 mai 2021 S | 115 331 | 0 | 0 | $0 |
| David M Denton | EVP and CFO | 29 novembre 2018 S | 403 | 0 | 0 | $0 |
| David B Rickard | Chief Financial Officer | 14 décembre 2009 M | 207 179 | 0 | 0 | $0 |
| Howard A Mclure | President, Caremark Pharm Serv | 2 novembre 2009 M | 0 | 0 | 0 | $0 |
| Jonathan C Roberts | EVP & Chief Operating Officer | 1 avril 2022 A | 426 025 | 0 | 0 | $0 |
| James David Clark | SVP, Cont & Chief Acct Officer | 26 juin 2026 F | 27 606 | 0 | 0 | $0 |
| Amy Compton-Phillips | EVP, Chief Medical Officer | 31 mai 2026 F | 9 557 | 0 | 0 | $0 |
| Tilak Mandadi | EVP, Chief Exp & Tech Officer | 8 mai 2026 S | 10 133 | 0 | 1 | $-6 230 379 |
| Prem S Shah | EVP and Group President | 31 mars 2026 A | 64 356 | 0 | 0 | $0 |
| Heidi B Capozzi | EVP and Chief People Officer | 31 mars 2026 A | 13 023 | 3 | 0 | $4 588 |
| Samrat S. Khichi | EVP, CPO and General Counsel | 31 mars 2026 A | 33 421 | 0 | 0 | $0 |
| Steven H Nelson | EVP and President, Aetna | 31 mars 2026 A | 2 900 | 1 | 0 | $1 289 |
| Sreekanth K Chaguturu | EVP and Chief Medical Officer | 1 avril 2024 A | 23 666 | 0 | 0 | $0 |
| Laurie P. Havanec | EVP and Chief People Officer | 1 avril 2024 A | 9 426 | 0 | 0 | $0 |
| Brian A Kane | EVP/President, Aetna | 1 avril 2024 A | 12 569 | 0 | 0 | $0 |
| Finke Daniel P | EVP/Pres, Health Care Benefits | 1 avril 2023 A | 35 068 | 0 | 0 | $0 |
| Michelle A Peluso | EVP and Co-President of Retail | 1 avril 2023 A | 124 383 | 0 | 0 | $0 |
| Thomas M Moriarty | EVP & General Counsel | 31 décembre 2022 F | 315 273 | 0 | 0 | $0 |
| Alan Lotvin | EVP&President-PharmacyServices | 4 août 2022 M | 109 183 | 0 | 0 | $0 |
| Troyen A Brennan | EVP and Chief Medical Officer | 3 avril 2022 F | 232 676 | 0 | 0 | $0 |
| Neela Montgomery | EVP and Pres., Pharmacy/Retail | 1 avril 2021 A | 29 502 | 0 | 0 | $0 |
| Lisa Bisaccia | Former EVP & Chief HR Officer | 1 avril 2021 F | 66 417 | 0 | 0 | $0 |
| Joshua Matthew Flum | EVP, ENT STRATEGY & DIGITAL | 28 février 2021 F | 25 657 | 0 | 0 | $0 |
| Jonathan E. Mayhew | EVP - Transformation | 2 décembre 2020 F | 6 855 | 0 | 0 | $0 |
| Derica W Rice | EVP & President, CVS Caremark | 28 février 2020 F | 26 827 | 0 | 0 | $0 |
| Kevin Hourican | EVP & President, CVS Pharmacy | 1 avril 2019 A | 15 237 | 0 | 0 | $0 |
| Helena Foulkes | EVP & President-CVS Pharmacy | 16 février 2018 M | 45 107 | 0 | 0 | $0 |
| Robert O. Kraft | EVP and President - Omnicare | 3 avril 2017 A | 92 360 | 0 | 0 | $0 |
| Andrew Sussman | EVP, Clinical Services | 3 avril 2017 A | 16 433 | 0 | 0 | $0 |
| Stephen J Gold | EVP & CIO | 3 avril 2017 A | 46 818 | 0 | 0 | $0 |
| Per Gh Lofberg | EVP | 2 janvier 2015 M | 23 419 | 0 | 0 | $0 |
| Mark Cosby | EVP & President-CVS/pharmacy | 30 septembre 2013 M | 45 955 | 0 | 0 | $0 |
| Laird Daniels | SVP, Cont & Chief Acct Officer | 1 avril 2013 A | 17 845 | 0 | 0 | $0 |
| Douglas A Sgarro | EVP and CLO | 11 mai 2012 M | 214 | 0 | 0 | $0 |
| Stuart M Mcguigan | SVP and CIO | 16 mars 2012 M | 10 967 | 0 | 0 | $0 |
| Thomas M Ryan | Non-Executive Chairman | 3 avril 2011 F | 1 156 702 | 0 | 0 | $0 |
| Sara Finley | SVP, Gen Counsel | 18 février 2011 F | 29 053 | 0 | 0 | $0 |
| Michael V Ferdinandi | Senior Vice President | 19 août 2009 S | 16 021 | 0 | 0 | $0 |
| Paula A Price | Controller | 12 février 2008 A | 16 498 | 0 | 0 | $0 |
| Edwin M Crawford | Chairman | 29 octobre 2007 A | 135 572 | 0 | 0 | $0 |
| William R Spalding | EVP Caremark Pharmacy Services | 18 juin 2007 M | 182 | 0 | 0 | $0 |
| Gregory S Weishar | Vice President | 3 avril 2006 A | 30 161 | 0 | 0 | $0 |
| Larry D Solberg | Senior Vice President | 16 février 2006 A | 5 978 | 0 | 0 | $0 |
| ROBBINS LARRY | Administrateur | 21 mai 2026 S | 4 824 799 | 0 | 8 | $-352 750 556 |
| Fernando Aguirre | Administrateur | 21 mai 2026 D | 10 513 | 0 | 0 | $0 |
Initiés issus des déclarations SEC Form 3/4/5 ; net = uniquement P/S de marché
Activistes et détenteurs de 5%+ 1 participation
Investisseurs ayant déposé un Schedule 13D auprès de la SEC — détention effective supérieure à 5% avec l'intention d'influencer l'émetteur (participations activistes, campagnes pour le conseil d'administration, fusions-acquisitions). Chaque ligne montre le dernier état connu de la position du déposant.
| Déclarant | Déposé | Participation | Statut | Objectif | Dépôt |
|---|---|---|---|---|---|
| CVS Caremark Corporation | 7 janvier 2011 | — | Dépôt initial | Fusions et acquisitions / vente | SEC |
Purpose is an automated classification of the filer's own stated purpose (SEC Item 4) — not investment advice. "—" means no clear purpose was stated or the text could not be classified.
Détention d'ETF Détenu par 228 ETFs
Le poids reflète uniquement les participations directes en actions (N-PORT) ; les fonds à effet de levier ou basés sur des dérivés peuvent détenir une exposition supplémentaire aux swaps non indiquée.
| Fonds | Poids | Unités | Au | Source |
|---|---|---|---|---|
| IHF · iShares Trust | 13,21% | 1 722 315 SH | 21 août 2026 | Quotidien |
| ROPE · EA Series Trust | 5,27% | 4 922 NS | 29 mai 2026 | N-PORT |
| DUSA · Davis Fundamental ETF Trust | 4,57% | 636 042 NS | 30 avril 2026 | N-PORT |
| IYK · iShares Trust | 4,10% | 619 457 SH | 21 août 2026 | Quotidien |
| GEND · Spinnaker ETF Series | 3,66% | 1 968 NS | 30 avril 2026 | N-PORT |
| PEZ · Invesco Exchange-Traded Fund Trust | 3,56% | 8 583 SH | 21 août 2026 | Quotidien |
| JDOC · J.P. Morgan Exchange-Traded Fund Tr… | 2,71% | 3 618 NS | 30 avril 2026 | N-PORT |
| ESN · Northern Lights Fund Trust II | 2,58% | 79 142 NS | 31 mai 2026 | N-PORT |
| DWLD · Davis Fundamental ETF Trust | 2,33% | 158 312 NS | 30 avril 2026 | N-PORT |
| SDOG · ALPS ETF Trust | 2,25% | 342 879 NS | 31 mai 2026 | N-PORT |
| COWZ · Pacer Funds Trust | 2,16% | 4 706 232 NS | 30 avril 2026 | N-PORT |
| QQWZ · Pacer Funds Trust | 2,15% | 12 078 NS | 30 avril 2026 | N-PORT |
| VHT · VANGUARD WORLD FUND | 1,94% | 3 824 297 SH | 19 août 2026 | Quotidien |
| RWL · Invesco Exchange-Traded Fund Trust … | 1,92% | 2 032 869 SH | 21 août 2026 | Quotidien |
| FXG · First Trust Exchange-Traded AlphaDE… | 1,89% | 55 579 NS | 30 avril 2026 | N-PORT |
| SPDV · ETF Series Solutions | 1,86% | 20 100 NS | 30 avril 2026 | N-PORT |
| RPV · Invesco Exchange-Traded Fund Trust | 1,82% | 335 743 SH | 21 août 2026 | Quotidien |
| FHLC · FIDELITY COVINGTON TRUST | 1,71% | 585 200 NS | 30 avril 2026 | N-PORT |
| RXL · ProShares Trust | 1,67% | 13 266 NS | 31 mai 2026 | N-PORT |
| REVS · Columbia ETF Trust I | 1,55% | 52 621 NS | 30 avril 2026 | N-PORT |
| CURE · Direxion Shares ETF Trust | 1,53% | 25 368 NS | 30 avril 2026 | N-PORT |
| IXJ · iShares Trust | 1,44% | 670 400 SH | 21 août 2026 | Quotidien |
| SPVM · Invesco Exchange-Traded Fund Trust | 1,43% | 20 951 SH | 21 août 2026 | Quotidien |
| RSPH · Invesco Exchange-Traded Fund Trust | 1,38% | 121 065 SH | 21 août 2026 | Quotidien |
| ITAN · EA Series Trust | 1,36% | 13 295 NS | 29 mai 2026 | N-PORT |
| PWV · Invesco Exchange-Traded Fund Trust | 1,34% | 265 424 SH | 21 août 2026 | Quotidien |
| VLUE · iShares Trust | 1,31% | 1 367 833 SH | 21 août 2026 | Quotidien |
| DVY · iShares Trust | 1,31% | 3 337 377 SH | 21 août 2026 | Quotidien |
| KNGZ · First Trust Exchange-Traded Fund VI | 1,21% | 7 277 NS | 30 juin 2026 | N-PORT |
| GMOV · GMO ETF Trust | 1,21% | 12 118 NS | 31 mai 2026 | N-PORT |
| CGVV · Capital Group Equity ETF Trust I | 1,20% | 18 109 NS | 31 mai 2026 | N-PORT |
| GURU · Global X Funds | 1,17% | 8 187 NS | 30 avril 2026 | N-PORT |
| BSCS · Invesco Exchange-Traded Self-Indexe… | 1,17% | 40 484 000 | 21 août 2026 | Quotidien |
| SPVU · Invesco Exchange-Traded Fund Trust … | 1,13% | 16 706 NS | 31 mai 2026 | N-PORT |
| SPXD · DBX ETF Trust | 1,12% | 830 NS | 31 mai 2026 | N-PORT |
| VRP · Invesco Exchange-Traded Fund Trust … | 1,09% | 31 147 000 | 21 août 2026 | Quotidien |
| CVAR · ETF Opportunities Trust | 1,01% | 4 716 NS | 30 avril 2026 | N-PORT |
| CGCV · Capital Group Conservative Equity E… | 0,99% | 189 872 NS | 31 mai 2026 | N-PORT |
| PALC · Pacer Funds Trust | 0,98% | 27 132 NS | 30 avril 2026 | N-PORT |
| ABCS · EA Series Trust | 0,98% | 1 219 NS | 29 mai 2026 | N-PORT |
| FFLV · FIDELITY COVINGTON TRUST | 0,97% | 2 025 NS | 30 avril 2026 | N-PORT |
| VFVA · VANGUARD WELLINGTON FUND | 0,95% | 77 895 SH | 19 août 2026 | Quotidien |
| FNDX · SCHWAB STRATEGIC TRUST | 0,91% | 2 553 383 NS | 31 mai 2026 | N-PORT |
| EQWL · Invesco Exchange-Traded Fund Trust | 0,90% | 270 040 SH | 21 août 2026 | Quotidien |
| IUS · Invesco Exchange-Traded Self-Indexe… | 0,86% | 89 017 SH | 21 août 2026 | Quotidien |
| AKAF · ETF Series Solutions | 0,84% | 271 NS | 31 mai 2026 | N-PORT |
| FNDB · SCHWAB STRATEGIC TRUST | 0,83% | 120 850 NS | 31 mai 2026 | N-PORT |
| WBIG · Absolute Shares Trust | 0,82% | 2 174 NS | 30 juin 2026 | N-PORT |
| RECS · Columbia ETF Trust I | 0,81% | 529 096 NS | 30 avril 2026 | N-PORT |
| FEUS · FlexShares Trust | 0,81% | 10 773 NS | 30 avril 2026 | N-PORT |